| Entry |
|
|---|
| Name |
Bornaprine (INN) |
|---|
| Formula |
C21H31NO2
|
|---|
| Exact mass |
329.2355
|
|---|
| Mol weight |
329.4763
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG01745 Anticholinergic antiparkinson agent
|
|---|
| Remark |
|
|---|
| Efficacy |
Antiparkinsonian |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS
N04A ANTICHOLINERGIC AGENTS
N04AA Tertiary amines
N04AA11 Bornaprine
D07302 Bornaprine (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG01745 Anticholinergic antiparkinson agent
D07302 Bornaprine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM
D07302 Bornaprine (INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 24
1 C1x C 11.5500 -15.8900
2 C1x C 11.5500 -17.2900
3 C1y C 12.7624 -17.9900
4 C1x C 13.9749 -17.2900
5 C1z C 13.9749 -15.8900
6 C1y C 12.7624 -15.1900
7 C8y C 13.9749 -14.4900
8 C7a C 15.1873 -16.5900
9 O7a O 16.4024 -15.8900
10 C1b C 17.6149 -16.5900
11 C1b C 18.8273 -15.8900
12 C1b C 20.0397 -16.5900
13 N1c N 21.2522 -15.8900
14 C8x C 15.2060 -13.7790
15 C8x C 15.2058 -12.3790
16 C8x C 13.9933 -11.6792
17 C8x C 12.7622 -12.3902
18 C8x C 12.7624 -13.7902
19 O6a O 15.1867 -17.9900
20 C1b C 22.4853 -16.6022
21 C1b C 21.2523 -14.4903
22 C1a C 22.4855 -13.7781
23 C1a C 23.6915 -15.9060
24 C1x C 12.0624 -16.4024
BOND 26
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 5 7 1
8 5 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 7 14 2
15 14 15 1
16 15 16 2
17 16 17 1
18 17 18 2
19 7 18 1
20 8 19 2
21 13 20 1
22 13 21 1
23 21 22 1
24 20 23 1
25 6 24 1
26 24 3 1
|
|---|
